BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 855 filers reported holding BAXTER INTL INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $87,000 | +3.6% | 1,340 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $84,000 | +3.7% | 1,340 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $81,000 | +50.0% | 1,340 | +29.5% | 0.00% | 0.0% |
| Q1 2017 | $54,000 | -97.6% | 1,035 | -98.0% | 0.00% | -97.9% |
| Q4 2016 | $2,264,000 | -4.4% | 51,070 | +2.7% | 0.14% | -44.4% |
| Q3 2016 | $2,367,000 | +678.6% | 49,750 | +437.8% | 0.26% | +536.6% |
| Q3 2015 | $304,000 | -53.0% | 9,250 | 0.0% | 0.04% | -45.3% |
| Q2 2015 | $647,000 | -4.6% | 9,250 | 0.0% | 0.08% | -6.2% |
| Q4 2014 | $678,000 | +32.2% | 9,250 | +29.4% | 0.08% | +21.2% |
| Q3 2014 | $513,000 | -0.8% | 7,150 | 0.0% | 0.07% | -21.4% |
| Q2 2014 | $517,000 | -1.7% | 7,150 | 0.0% | 0.08% | -29.4% |
| Q1 2014 | $526,000 | +11.9% | 7,150 | 0.0% | 0.12% | -53.7% |
| Q3 2013 | $470,000 | – | 7,150 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |